With management forecasting a 23% to 30% rise in earnings before interest, tax, depreciation, and amortisation in FY 2017, it doesn't come as a surprise to see the share price bolt higher today. Mayne Pharma Group Ltd ( ASX: MYX ) shares are up 3% to $1.99 after releasing its full year results to the market. The growing Australian pharmaceutical company posted a stunning 379% jump in net profit to $37.4 million. The great news for shareholders is that these results do not include the recently acquired portfolio of drugs from industry giants Teva Pharmaceuticals and Allergan. This lucrative acquisition closed earlier this month and is expected to be significantly accretive to earnings moving forward. St Barbara Ltd ( ASX: SBM ) shares have jumped 5% to $3.08 after the gold miner announced that its credit rating had been upgraded by Moody's. The rating agency lifted St Barbara from a B3 rating to a B2 with a positive outlook.